UCI Health lowered deaths from antibiotic-resistant organisms by 24% with this collaboration

A study led by researchers at Orange, Calif.-based UCI Health found that use of antiseptic soap and nasal ointment among patients in hospitals and residents of nursing homes reduced countywide infections by up to 30% and dropped associated deaths by 24%.

Advertisement

The study, published April 1 in JAMA, analyzed quality improvements across 35 healthcare facilities in Orange County, Calif., between July 2017 and July 2019. The study analyzed methods of decolonization associated with reducing regional multidrug-resistant organisms prevalence, incident clinical cultures, and infection-related hospitalizations, costs and deaths. Of the 35 facilities in the study, 16 were hospitals, 16 were nursing homes and three were long-term acute care hospitals.

The study looked at regional interventions to mitigate multidrug-resistant organisms and associated infections. Here are four findings:

  • At facilities that adopted the intervention, The mean prevalence of multidrug-resistant organisms decreased from 63.9% to 49.9% among nursing homes, from 80% to 53.3% among long-term care hospitals and from 64.1% to 55.4% among hospitalized patients in hospitals.
  • A patient cleansing protocol, known as decolonization, at nursing homes helped reduce monthly incident MDRO-positive clinical cultures from 2.7 to 1.7, compared to a change of 1.7 to 1.5 among non-participating nursing homes.
  • The rate of infection-related hospitalizations per 1,000 resident-days dropped from 2.31 to 1.94 during intervention.
  • Associated hospitalization costs per 1,000 resident-days dropped from $64,651 to $55,149 among participating nursing homes, compared to a roughly $4,000 increase for non-participating nursing homes.

“A regional collaborative involving universal decolonization in long-term care facilities and targeted decolonization among hospital patients in contact precautions was associated with lower multidrug-resistant organism carriage, infections, hospitalizations, costs and deaths,” the study authors wrote.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Post-Acute

Advertisement

Comments are closed.